12 Development of an in vitro assay to assess bispecific T cell engager using T cells from CD3e humanized mice
Zhou, Jun, Zhu, Shuang, Zhang, Hongjuan, Zheng, Lei, Zang, Mingfa, An, Annie Xiaoyu, Wang, Shuzong, Ouyang, Davy Xuesong, Li, Henry, Huang, Yujun
Published in Journal for immunotherapy of cancer (01.11.2020)
Published in Journal for immunotherapy of cancer (01.11.2020)
Get full text
Journal Article
237 In vitro potency assays for immune checkpoint blockade using human primary cells, murine huGEMM immune cells and patient-derived tumor organoids
Yan, Xuefei, Zhang, Hongjuan, Zhou, Jun, Zheng, Jia, Zhu, Shuang, Zhang, Rui, Zang, Mingfa, An, Annie Xiaoyu, Xu, Xiaoxi, Wang, Shuzong, Xu, Kevin Qijin, Ouang, Davy Xuesong, Li, Henry, Huang, Yujun
Published in Journal for immunotherapy of cancer (01.11.2020)
Published in Journal for immunotherapy of cancer (01.11.2020)
Get full text
Journal Article
527 Tumor organoid and immune cell co-culture system potentiates immuno-oncology drug development
Zhang, Hongjuan, Zhou, Jun, Zhu, Shuang, Zheng, Jia, Shang, Limei, Li, Chunmei, Yan, Xuefei, Zhang, Rui, Zang, Mingfa, An, Annie Xiaoyu, Xu, Xiaoxi, Wang, Shuzong, Li, Henry, Huang, Yujun
Published in Journal for immunotherapy of cancer (01.11.2020)
Published in Journal for immunotherapy of cancer (01.11.2020)
Get full text
Journal Article
Abstract 4621: Developing genetically modified homograft models of mouse prostate cancer for efficacy evaluation of combinatory immunotherapies
Wang, Jessie Jingjing, Song, Yanrui, An, Annie Xiaoyu, Zhang, Likun, Li, Henry Qixiang, Ouyang, Davy Xuesong
Published in Cancer research (Chicago, Ill.) (01.07.2019)
Published in Cancer research (Chicago, Ill.) (01.07.2019)
Get full text
Journal Article
Abstract C102: Investigation of the mechanism of action of anti-PD-1 treatment by systematic depletion of different immune cell populations in syngeneic models
Jin, Ying, Shan, Yongli, An, Annie Xiaoyu, Li, Henry Qixiang, Ouyang, Davy Xuesong
Published in Molecular cancer therapeutics (01.12.2019)
Published in Molecular cancer therapeutics (01.12.2019)
Get full text
Journal Article
Abstract 5615: Anti-human CD47 antibody Hu5F9 inhibits MC38 tumor growth in hCD47/hSIRPα double knock-in mice
He, Daniel Xianfei, Nie, Chenpan, Zheng, Lei, Sun, Ruilin, An, Annie Xiaoyu, Li, Henry Q. x., Ouyang, Davy Xuesong
Published in Cancer research (Chicago, Ill.) (15.08.2020)
Published in Cancer research (Chicago, Ill.) (15.08.2020)
Get full text
Journal Article
Abstract 5616: Characterization of a spectrum of DTR models for conditional depletion of specific immune cell lineages
Jin, Ying, Zhou, Jiahua, Li, Fengge, Sun, Ruilin, An, Annie Xiaoyu, Li, Henry Q. X., Ouyang, Davy Xuesong
Published in Cancer research (Chicago, Ill.) (15.08.2020)
Published in Cancer research (Chicago, Ill.) (15.08.2020)
Get full text
Journal Article
Abstract 502: In vitro characterization of antibodies targeting the SIRPα-CD47 phagocytosis checkpoint using tumor-associated macrophages from HuGEMM™ mice
Yan, Xuefei, Zhang, Hongjuan, Liu, Yi, Zhang, Yahong, Zheng, Lei, Zang, Mingfa, An, Annie Xiaoyu, Xu, kevin Qijin, Ouyang, Davy, Li, Henry, Huang, Yujun
Published in Cancer research (Chicago, Ill.) (01.07.2021)
Published in Cancer research (Chicago, Ill.) (01.07.2021)
Get full text
Journal Article
Abstract 2375: Developing double knock-in models of human immune checkpoint targets (dKI HuGEMM) for efficacy assessment of combinatorial therapeutic antibodies
Zheng, Lei, He, Daniel Xianfei, Sun, Ruilin, An, Annie Xiaoyu, Fei, Jian, Li, Henry Qixiang, Ouyang, Davy Xuesong
Published in Cancer research (Chicago, Ill.) (01.07.2019)
Published in Cancer research (Chicago, Ill.) (01.07.2019)
Get full text
Journal Article
Abstract 4976: Ex vivo functional characterization and in vivo efficacy validation of human CD40 agonistic antibodies in the human CD40 knock-in model (CD40 HuGEMM)
He, Daniel Xianfei, Zheng, Lei, Sun, Ruilin, An, Annie Xiaoyu, Fei, Jian, Li, Henry Qixiang, Ouyang, Davy Xuesong
Published in Cancer research (Chicago, Ill.) (01.07.2019)
Published in Cancer research (Chicago, Ill.) (01.07.2019)
Get full text
Journal Article
Abstract A010: Development of OVA-expressing immunogenic syngeneic mouse tumor models: CT26-OVA and B16-OVA
Jin, Ying, Wang, Phillip Shuzong, Li, Zhongliang, An, Annie Xiaoyu, Zhou, Jiahua, Li, Henry Qixiang, Ouyang, Davy Xuesong
Published in Molecular cancer therapeutics (01.12.2019)
Published in Molecular cancer therapeutics (01.12.2019)
Get full text
Journal Article
Abstract 5614: Combination of anti-TIGIT and anti-PD-1 antibodies enhance antitumor response in a PD-1/TIGIT double HuGEMM™ model engrafted with mouse syngeneic tumors
He, Daniel Xianfei, Nie, Chenpan, Zheng, Lei, Sun, Ruilin, Zhang, Mingkun, An, Annie Xiaoyu, Ju, Cunxiang, Li, Henry Q. X., Ouyang, Davy Xuesong
Published in Cancer research (Chicago, Ill.) (15.08.2020)
Published in Cancer research (Chicago, Ill.) (15.08.2020)
Get full text
Journal Article
Abstract 1144: Building Kras (G12D)/Trp53 null/Pdx1-cre (KPC) mouse allograft tumor model for efficacy evaluation of combinatory immunotherapies
Song, Yanrui, Liu, Benqi, An, Annie Xiaoyu, Zhang, Likun, Cai, Jie, Shi, Qian, Li, Henry Qixiang, Ouyang, Davy Xuesong
Published in Cancer research (Chicago, Ill.) (01.07.2018)
Published in Cancer research (Chicago, Ill.) (01.07.2018)
Get full text
Journal Article
Abstract A003: Developing an AML mouse syngeneic model for combinatory chemotherapy and immunotherapy
Tang, Xin, Tong, Lily, An, Annie Xiaoyu, Zhang, Likun, Cai, Jie, Shi, Qian, Wery, Jean Pierre, Ouyang, Davy Xuesong
Published in Molecular cancer therapeutics (01.01.2018)
Published in Molecular cancer therapeutics (01.01.2018)
Get full text
Journal Article
Abstract A207: Utilizing human OX40 knock-in mice (HuGEMMTM) to assess antitumor efficacy of OX40-agonistic antibodies
Huang, Xuesong, Zheng, Lei, Ouyang, Wenyi, Zhang, Mingkun, An, Annie Xiaoyu, Zhao, Jing, Gao, Xiang, Wery, Jean Pierre, Shi, Qian
Published in Molecular cancer therapeutics (01.01.2018)
Published in Molecular cancer therapeutics (01.01.2018)
Get full text
Journal Article
Abstract 2807: Developing a variety of primary mouse tumor allograft models for evaluating efficacy of PARP inhibitor
Qu, Gavin Jiagui, Ouyang, Davy Xuesong, Chen, Li, Zhang, Likun, An, Annie Xiaoyu, Cai, Jie, Li, Henry Q. X.
Published in Cancer research (Chicago, Ill.) (01.07.2017)
Published in Cancer research (Chicago, Ill.) (01.07.2017)
Get full text
Journal Article
Abstract 5669: Establishment of a human CD3ε transgenic mouse model to assess anti-tumor efficacy of human T-cell-redirecting bispecific antibodies
Yang, Mengmeng, Zhang, Mingkun, Verploegen, Sandra, Engelberts, Patrick, Zhang, Yuxi, Zheng, Lei, Zhu, Keyi, An, Annie Xiaoyu, Ju, Cunxiang, Zhao, Jing, Gao, Xiang, Shi, Qian, Ouyang, Davy Xuesong
Published in Cancer research (Chicago, Ill.) (01.07.2018)
Published in Cancer research (Chicago, Ill.) (01.07.2018)
Get full text
Journal Article
Abstract 4168: BALB/c-CD3EDG HuGEMMTM mouse model for evaluation of CD3-targeted tumor immunotherapy
Liu, Demi Xiaojuan, Lian, Kaixia, Yan, Xuefei, Lin, Jie, Zheng, Lei, Xiaoyu An, Annie, Xu, Xiaoxi, Bourre, Ludovic, Wang, Jingjing
Published in Cancer research (Chicago, Ill.) (04.04.2023)
Published in Cancer research (Chicago, Ill.) (04.04.2023)
Get full text
Journal Article